Journalist

Kim Dong-young
Kim Dong-young김동영
ReporterSamsung Biologics, CJ CheilJedang, LG Chem, Celltrion, Naver, Krafton, Nexon, Hyundai Mobis etc. & energy, game, food, bio, petrochemical, AI
Kim Dong-young is a bilingual journalist at AJU Press (AJP), covering Korean tech, energy, and bio/pharma.
He reports from the field at events like CES and APEC, runs AJP's YouTube channels,
and is pursuing a master's at Sogang's MOT program. "I try everything in this AI era that can improve yet preserve the facts. Journalism still serves as my core."
Lotus transforms Seoul showroom into immersive art gallery Lotus transforms Seoul showroom into immersive art gallery

Lotus transforms Seoul showroom into immersive art gallery

Naver, Spotify open joint popup store in Seoul to showcase audio content partnership Naver, Spotify open joint popup store in Seoul to showcase audio content partnership

Naver, Spotify open joint popup store in Seoul to showcase audio content partnership

Samsung Biologics acquires GSK biopharmaceutical plant in U.S. for $280 million Samsung Biologics acquires GSK biopharmaceutical plant in U.S. for $280 million

Samsung Biologics acquires GSK biopharmaceutical plant in U.S. for $280 million

CJ CheilJedang brings Bibigo brand to Netflixs Culinary Class Wars Season 2 CJ CheilJedang brings Bibigo brand to Netflix's Culinary Class Wars Season 2

CJ CheilJedang brings Bibigo brand to Netflix's Culinary Class Wars Season 2

Koreas shipbuilders to extend order growth streak in 2026 Korea's shipbuilders to extend order growth streak in 2026

Korea's shipbuilders to extend order growth streak in 2026

Kosdaq-heading chip design house SemiFive prices IPO at top of range Kosdaq-heading chip design house SemiFive prices IPO at top of range

Kosdaq-heading chip design house SemiFive prices IPO at top of range

Another turbulent year looms for Koreas petrochemical industry in 2026 Another turbulent year looms for Korea's petrochemical industry in 2026

Another turbulent year looms for Korea's petrochemical industry in 2026

Celltrion launches Eylea biosimilar in Europe, secures UK healthcare tenders Celltrion launches Eylea biosimilar in Europe, secures UK healthcare tenders

Celltrion launches Eylea biosimilar in Europe, secures UK healthcare tenders

GM Korea dismisses exit speculation, pledges $300 million investment for 2026 GM Korea dismisses exit speculation, pledges $300 million investment for 2026

GM Korea dismisses exit speculation, pledges $300 million investment for 2026

SK On expands at home with big bet on LFP amid uncertainty in global battery market SK On expands at home with big bet on LFP amid uncertainty in global battery market

SK On expands at home with big bet on LFP amid uncertainty in global battery market